1.A review of the carbon disulfide poisoning experiences in Korean.
Jae Wook CHOI ; Soung Hoon JANG
Korean Journal of Occupational and Environmental Medicine 1991;3(1):11-20
No abstract available.
Carbon Disulfide*
;
Carbon*
;
Poisoning*
2.Characterization of Severe Acute Respiratory Syndrome Coronavirus 2Stability in Multiple Water Matrices
Young Jae LEE ; Je Hyoung KIM ; Byeong-Sun CHOI ; Jang-Hoon CHOI ; Young-Il JEONG
Journal of Korean Medical Science 2020;35(36):e330-
The advent of the global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) necessitates a thorough study of the stability and transmissibility in the environment. We characterized the stability of SARS-CoV-2 in three water matrices: fresh, tap, and seawater. The minimum infective dose of SARS-CoV-2 in Vero cells was confirmed to be 10 3 PFU/mL. The stability of SARS-CoV-2 varied according to the water matrix: infective SARSCoV-2 was undetectable after treatment with fresh water and seawater, but remained detectable for 2 days in tap water, when starting with an initial concentration of 10 4 PFU/mL. When the starting concentration was increased to 10 5 PFU/mL, a similar trend was observed. In addition, viral RNA persisted longer than infectious virus in all water matrices. This study was conducted in stagnant water containing a significantly high titer of virus, thus, human-to-human transmission of SARS-CoV-2 through the actual aquatic environment is expected to be rare.
3.Spontaneous Pulmonary Hemorrhage and Adult Respiratory Distress Syndrome after Thrombolytic Therapy for Acute Myocardial Infarction.
Jun Gu LEE ; Dong Hoon CHOI ; Seok Min KANG ; Yang Soo JANG
Korean Circulation Journal 1997;27(5):554-558
We report a cace of 69-year-old man who developed massive pulmonary hemorrhage and subsuquent adult respiratory distress syndrome following intravenous urokinase for acute myocardial infarction. Pulmonary hemorrhage is a rare but a potentially life-threatening complication after thrombolytic therapy and should be considered in the differential diagnosis of pulmonary infiltrates of falling hemoglobin after thrombolytic therapy for acute myocardial infarction with no obvious site of bleeding.
Adult*
;
Aged
;
Diagnosis, Differential
;
Hemorrhage*
;
Humans
;
Myocardial Infarction*
;
Respiratory Distress Syndrome, Adult*
;
Thrombolytic Therapy*
;
Urokinase-Type Plasminogen Activator
4.The Structural Properties of Israeli Carp ( Cyprinus carpio L. ) Immunoglobulin.
Sang Hoon CHOI ; Jong Kyu WOO ; Yong Suk JANG ; Chan Ho OH
Korean Journal of Immunology 1999;21(1):85-92
Serum immunoglobulins from Israeli carp (I. carp) were purified using affinity chromatography. Fish were immunized with purified mouse IgG, and the specific fish antibodies purified from the immune serum on a mouse IgG-immobilized agarose gel. Rabbit anti-carp Ig (Raclg) antibodies were produced following hyperimmunization with mlgG specific I. Carp Ab. SDS-PAGE analysis under reducing condition showed that I. carp Ig (clg) were composed of two u-like heavy chains with about 82 and 50 kD, respectively and one light chain with about 25 kD. On immunoblotting analysis, however, Raclg failed to react with light chain. When both protein A and protein G purified normal clg were compared with mlgG specific clg, no significant structural differences among them were observed. To investigate if there is any homology between other fish Ig molecules, cross-reactivity of Raclg against Ig molecules from 6 different fish sera and mouse control serum was checked on immunoblotting analysis. As a result, Raclg responded to only carp and tilapia Ig molecules, indicating that both tilapia and carp are very closely associated, especially, in the genetic basis of immunoglobulin structure. In flow cytometry study, Raclg appeared to recognize 45.8% of carp Ig+, 14.5% of catfish Ig+ and <5% of tilapia Ig+ cells. The result suggest the heterogeniety between receptor immunoglobulins on B-like lymphocytes and soluble immunoglobulins in serum. It is crucial to obtain pure fish immunoglobulins to produce reagent antibodies as tools for the study of their specific immune response.
Animals
;
Antibodies
;
Carps*
;
Catfishes
;
Chromatography, Affinity
;
Electrophoresis, Polyacrylamide Gel
;
Flow Cytometry
;
Immunoblotting
;
Immunoglobulin G
;
Immunoglobulins*
;
Lymphocytes
;
Mice
;
Sepharose
;
Staphylococcal Protein A
;
Tilapia
5.Early Results of Subclavian Artery Stenting.
Wook Bum PYUN ; Young Sup YOON ; Dong Hoon CHOI ; Yang Soo JANG ; Won Heum SHIM
Korean Circulation Journal 1999;29(5):481-486
BACKGROUND AND OBJECTIVES: Though the surgical intervention of subclavian artery stenosis has been effective, its high morbidity and mortality have limited its clinical application. In 1980 percutaneous balloon angioplasty of stenotic artery was introduced as a substitute for surgical intervention and subsequent reports have supported its efficacy noting that it is more effective when combined with stent. The purpose of this study was to assess the feasibility, safety, and efficacy of percutaneous intervention as an alternative or primary therapy for symptomatic subclavian artery stenosis. METHODS: Between September 1993 and October 1998, 17 lesions in 16 patients of symptomatic subclavian artery stenosis were enrolled as candidates for nonsurgical intervention. We performed percutaneous balloon angioplasty with stenting to the subclavian artery stenosis and evaluated the early results. RESULTS: 1)The patients had a mean age of 55+/-14 years and 13 of 16 patients were male. 2)Subclavian artery stenting was successful in 94% (16/17) of the lesion without significant complications. The cause of failure was suboptimal result after deployment of stent. 3)The types of stents deployed were Strecker stents in 4, Palmaz stents in 8, Wall stents in 3 and Jo stents in 2 cases. 4)The peak and mean pressure gradient reduced from 58.5+/-17.0 to 8.5+/-7.4 and 31.4+/-13.0 to 4.7+/-5.5 mmHg respectively (p<0.01) and the degree of luminal stenosis decreased from 92.5+/-8.5% to 10.0+/-14.3%. (p<0.01) CONCLUSION: Subclavian artery stenosis can be managed safely and effectively through percutaneous balloon angioplasty with stenting, with an excellent technical success rate and less morbidity and mortality particularly in patients coexisting other vascular and systemic diseases. However, the long-term patency and clinical effects should be warranted.
Angioplasty, Balloon
;
Arteries
;
Constriction, Pathologic
;
Humans
;
Male
;
Mortality
;
Phenobarbital
;
Stents*
;
Subclavian Artery*
;
Subclavian Steal Syndrome
6.Stenting in Renal Artery Stenosis.
Dong Hoon CHOI ; Bum Kee HONG ; Won Heum SHIM ; Yangsoo JANG ; Seung Yun CHO
Korean Circulation Journal 1997;27(7):703-711
BACKGROUND: renal artery stenosis (RAS) is a major cause of renovascular hypertension and renal function due to ischemic atrophy of kidney. There are several methods to treat the RAS, including are surgery, percutaneous transluminal renal angioplasty, and medical treatment. The purpose of this study is to evaluate the usefulness, safety, and efficacy of percutaneous transluminal stent deployment in RAS. METHOD: From January 1995 to July 1996, 17 patients underwent renal stent implantation due to renal artery stenosis (11 male, 6 female). the mean age was 49 years old, one patient had both renal artery stenosis and total lesions were 18. The causes of renal artery stenosis were atherosclerosis in 12, fibromuscular dysplasia in 2, Takayasu's disease in 2, and autoimmune disease (Bechet's) in one case. Renal artery stenting was performed via femoral artery in 12 lesions and brachial artery in 6 lesions. Follow up was performed by renogram, renal angiogram, and clinical examination. RESULT: the degree of renal artery stenosis was 83% (70-95%). the lesion sites were 12 ostial and 6 non-ostial lesions. The used renal stents were Palmaz-biliary stent in 17 lesions and Micro-2 stent in one lesions. All stents were implanted successfully and there was no residual stenosis in all patients except one case showed 20% residual stenosis due to huge renal artery size. The transstenotic pressure gradients after renal artery stenting was decreased markedly from 74mmHg to 2mmHg. There no serious complications such as a death, emergency surgery, or nephrectomy. There were two minor complications which were one case of pyelonephritis and one case of inguinal hematoma. After stenting, blood pressure was decreased partially in 13 patients and completely in 2 cases. CONCLUSION: Renal artery stenting appears to be safe and feasible and the alternative treatment modality to surgery for renal artery stenosis.
Angioplasty
;
Atherosclerosis
;
Atrophy
;
Autoimmune Diseases
;
Blood Pressure
;
Brachial Artery
;
Constriction, Pathologic
;
Emergencies
;
Femoral Artery
;
Fibromuscular Dysplasia
;
Follow-Up Studies
;
Hematoma
;
Humans
;
Hypertension, Renovascular
;
Kidney
;
Male
;
Middle Aged
;
Nephrectomy
;
Pyelonephritis
;
Renal Artery Obstruction*
;
Renal Artery*
;
Stents*
7.A Clinical Study on Pathologic Fractures of Long Bones
Jang Suk CHOI ; Young Goo LEE ; Dae Hoon KIM ; Jung Hwan SON ; Jae Gong PARK
The Journal of the Korean Orthopaedic Association 1987;22(5):1069-1074
Pathologic fracture is a bresk of bony continuity within an abnormal bone. The abnormslity ma be due to systemic skeletal disease, infection, primary benign and malignant tumor, or metastati carcinoms. Among these, metastatic carcinoma to bone is most common cause of pathologic fractur excluding those due to osteoporosis. When considering the msnagement, pathologic fractures due to systemic skeletal disease usually heal with conservative treatment, while others often require operative treatment. We have experienced 20 cases of pathologic fracture in long bones for 8 years from 19 to 1987. The results were as follows ; 1. The average sge was somewhat different according to underlying diseases Malignant tumorous lesion; 53 years Benign tumorous lesion ; 17 years Chronic osteomyelitis, 42 years 2. The most common cause was malignant tumorous lesion, 8 cases(40%). 3. The most frequent site was femur, 17 cases(85%). 4. Surgical treatment was done in 17 cases(85%), and conservative treatment was done in 3 cas(1sw). 5. In 3 cases of pathologic fractures due to metaststic tumor, the pain was markedly relieved and essy nursing care was possible immediately after operation.
Clinical Study
;
Femur
;
Fractures, Spontaneous
;
Nursing Care
;
Osteomyelitis
;
Osteoporosis
8.A Clinical Study of Comminuted Fracture of Distal Humers in Adults
Ki Hong CHOI ; Chung Nam KANG ; Jin Man WANG ; Hoon Jae JANG
The Journal of the Korean Orthopaedic Association 1983;18(5):869-873
No abstract available in English.
Adult
;
Clinical Study
;
Fractures, Comminuted
;
Humans
9.The Effect of Amniotic Membrane Transplantation for Pterygium Excision.
Journal of the Korean Ophthalmological Society 2005;46(4):597-604
PURPOSE: In order to analyze the clinical efficacy of amniotic membrane transplantation, this study reviewed the literature on the treatments of pterygium with antimetabolites, radiation and conjunctival autograft. In addition, the outcome of simple excision with preserved human amniotic membrane transplantation in the treatment of a primary and recurrent pterygium were assessed. METHODS: A total of 28 eyes with pterygium (primary 11 eyes, recurrent 17 eyes) were treated with a simple excision and a preserved human amniotic membrane transplantation. A recurrence was defined as a regrowth of fibrovascular tissue invading the cornea. RESULTS: During a mean follow-up of 86 days, 2 (7%) recurrences were observed. One out of 11 eyes had a recurrence of the primary pterygium (9%), 1 out of 17 eyes had a recurrence of the recurrent pterygium (6%). No side effects or complications were observed. CONCLUSIONS: The simple excision of pterygium with amniotic membrane transplantation had a low recurrence rate and no side effects. The amniotic membrane transplantation is an effective method for treating pterygium.
Amnion*
;
Antimetabolites
;
Autografts
;
Cornea
;
Follow-Up Studies
;
Humans
;
Pterygium*
;
Recurrence
10.A Case of Sick Sinus Syndrome in Extremely Low Birth Weight Infant with Annular Pancreas.
Ji Eun KIM ; Siegfried BAUER ; Yoon Jung BOO ; Jang Hoon LEE ; Gi Young JANG ; Byung Min CHOI ; Moon Sung PARK
Journal of the Korean Society of Neonatology 2011;18(2):395-398
Sick sinus syndrome (SSS) is a disorder characterized by sinus node dysfunction. Although the condition is most common in the elderly, it can occur in children including neonates and its recognition and treatment are important. The diagnosis of SSS is based on the presence of sinus bradycardia, sinus arrest or exit block, combinations of sinoatrial and atrioventricular nodal conduction disturbances, and atrial tachyarrhythmias documented in the Holter recordings. In most children with SSS, previous history of congenital heart malformation or cardiac surgery is noted. SSS is also seen in the children including neonates without heart disease or other contributing factors, however SSS is most often idiopathic. The treatment of SSS depends on the basic rhythm problem, but generally involves the placement of a cardiac pacemaker. We report a case of SSS in extremely low birth weight infant without congenital heart disease and suggest that the treatment system is necessary for preterm infants with SSS.
Aged
;
Arrhythmias, Cardiac
;
Bradycardia
;
Child
;
Heart
;
Heart Diseases
;
Humans
;
Infant
;
Infant, Extremely Low Birth Weight
;
Infant, Newborn
;
Infant, Premature
;
Pancreas
;
Pancreatic Diseases
;
Premature Birth
;
Sick Sinus Syndrome
;
Tachycardia
;
Thoracic Surgery